30 closest matches · ranked by relevance
Endocrine System Diseases
Primary: Change From Baseline in Annual Growth Rate Standard Deviation Score (SDS) for Chronological Age (CA) at Month 36 in Intent-to-Treat (ITT) Population — -1.29; 2.36 SDS
Malnutrition · Developmental Disabilities
Primary: Change in Height/Length for Age Z Score — -0.02; 0.05 Z scores
Growth Hormone Deficiency · Panhypopituitarism · Short Stature
Primary: Reactive Hyperemic Response After 3 Months of Growth Hormone — 21.077 ml/dl min — p=0.644
Turner Syndrome
Primary: Total Brain Volume — 18.22; 19.78 percentage change
Parenting · Child Development
Primary: Mean Score of Depressive Symptoms Using the CES-D Scale — 5.59; 5.95; 4.17; 4.74 score on a scale
Growth Hormone Deficiency
Primary: Change From Baseline in Height Standard Deviation Score (SDS) for Chronological Age (CA) at Month 36: Full Analysis Population — -2.91; 0.80 Standard Deviation Score…
Osteogenesis Imperfecta
Primary: Proportion of Subjects Who Met Criteria of Increase in Growth Rate Since Baseline. — 25 Participants
Infant, Small for Gestational Age
Primary: Change From Baseline in Height Standard Deviation Score (SDS) at Month 24. — 1.63; 0.43 SDS — p=<0.001
Prematurity
Primary: Number of Participants With Weight<10th Percentile for Age — 32; 41 Participants
Pompe Disease · Glycogen Storage Disease Type II (GSD-II) · Acid Maltase Deficiency Disease
Primary: Recumbent Height/Length of Participants in Centimeters (cm) — 80.4; 93.8; 67.7; 91.1 cm
Infant, Very Low Birth Weight
Primary: Intestinal Microbiome Diversity — 55.7; 46.3 taxa represented
Growth Disorders
Primary: Number of Participants Who Died — 14; 96; 4; 7 participants
Turner Syndrome
Primary: Most Mature Height Standard Deviation Score (SDS) — -1.37; -1.60 standard deviation score
Cystic Fibrosis · Pancreatic Cystic Fibrosis
Primary: Change in Energy Intake From Baseline to Post Treatment — 485; 58 kilocalories per day — p=<0.001
Foetal Growth Problem · Small for Gestational Age
Primary: Change in Height Standard Deviation Score (SDS) for Chronological Age (CA) at Week 260 - Subjects Received NN220 Treatment for 5 Years — -2.9488; -2.9047; 1.2066; 2.0247…
Growth Hormone Deficiency
Primary: Annualized Height Velocity (AHV) Measured as Standing Height With Stadiometer — 0.098 cm/year
Growth Disorders · Insulin-Like Growth Factor-1 Deficiency
Primary: Height Velocity During the First Year - Intent to Treat (ITT)Population — 5.2; 6.9; 7.7 cm/yr — p=<0.0001
ADHD · Growth
Primary: Change Score for Z-height Baseline to Endpoint — -.04; -.11 Z score
Growth Hormone Deficiency · Septo-Optic Dysplasia · Hypopituitarism
Primary: Change in Anthropometric Measures Over Time — 1.97; -0.61; 1.39; 1.22 Z-score
Childhood Obesity
Primary: Objective 1 Primary Outcome: Change in Minutes of Sedentary Behavior, Light Physical Activity, and Moderate-to-vigorous Physical Activity — 21.4; 7.6; 1.0 Minutes…
Obesity
Primary: HsCRP — -1.1; 0.5; -1.3; -0.3 mg/L
Growth and Development
Primary: Number of Participants Who Achieved Tanner Stage V at or Before Age 16 (Females) or 17 (Males) — 4; 6 Participants
Idiopathic Short Stature · Failure to Thrive
Primary: Total Ghrelin Level — 1063; 1264; 1157 pg/mL
Short Stature
Primary: The Proportion of Children Maintaining Normal Growth Velocity — 23; 32; 31 Participants
Growth Disorders · Intrauterine Growth Retardation
Primary: Change From Baseline in Annual Growth Rate Measured at 2 Years Following Treatment With Genotonorm — 3.07; 3.97; 2.84 cm/year — p=0.02922
Asthma · Allergic Rhinitis
Primary: The Effect of Omnaris Nasal Spray & Alvesco Inhalation Aerosol vs Beconase AQ Nasal Spray & QVAR Inhalation Aerosol on Short-term Lower Leg Growth Velocity as Measured…
Obesity
Primary: Number of Participants Satisfied or Very Satisfied With Information Given to Them, as Measured by Follow up Questionnaire — 4; 2 Participants
Short Stature
Primary: Height Standard Deviation Score — -2.52; -1.57; -1.19; -1.09 standard deviation score
Fetal Growth Retardation
Primary: Percentage of Children With Insulin Growth Factor-1 (IGF-1) > 2 Standard Deviation (SD) at 9 and 12 Months — 86.0; 14.0 percentage of participants
Growth & Development · Child Development · Internship and Residency
Primary: Presence of Resident Surveillance Behaviors of Specific Aspects of Developmental Status at the Two Month Preventive Care Visit — 3 Participants